Milena Penkowa

Author PubWeight™ 44.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Retracted Exercise induces interleukin-8 expression in human skeletal muscle. J Physiol 2004 2.09
2 Retracted Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J 2005 1.39
3 Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle. J Physiol 2004 1.37
4 The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 2008 1.36
5 Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol 2007 1.34
6 Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol 2006 1.32
7 Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Malar J 2008 1.25
8 Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent. Glia 2003 1.19
9 Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling. Stroke 2007 1.13
10 Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J Biol Chem 2008 1.03
11 Fiber type specific expression of TNF-alpha, IL-6 and IL-18 in human skeletal muscles. Exerc Immunol Rev 2005 1.00
12 Metallothionein-1+2 protect the CNS after a focal brain injury. Exp Neurol 2002 0.96
13 Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family. J Neurochem 2007 0.95
14 Hydrocephalus induces dynamic spatiotemporal regulation of aquaporin-4 expression in the rat brain. Cerebrospinal Fluid Res 2010 0.94
15 Metallothionein-I+II in neuroprotection. Biofactors 2009 0.94
16 Retracted Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes 2005 0.93
17 Brain response to traumatic brain injury in wild-type and interleukin-6 knockout mice: a microarray analysis. J Neurochem 2005 0.93
18 In vivo expression of neuroglobin in reactive astrocytes during neuropathology in murine models of traumatic brain injury, cerebral malaria, and autoimmune encephalitis. Glia 2010 0.92
19 Exercise induces interleukin-8 receptor (CXCR2) expression in human skeletal muscle. Exp Physiol 2006 0.90
20 Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury. J Neurosci Res 2005 0.90
21 The Balance between Life and Death of Cells: Roles of Metallothioneins. Biomark Insights 2007 0.89
22 Metallothioneins I and II: neuroprotective significance during CNS pathology. Int J Biochem Cell Biol 2006 0.86
23 Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6. J Neuropathol Exp Neurol 2003 0.86
24 Generalization of DNA microarray dispersion properties: microarray equivalent of t-distribution. Biol Direct 2006 0.86
25 Cell death in the injured brain: roles of metallothioneins. Prog Histochem Cytochem 2008 0.86
26 Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: From gene to behavior. J Neurosci Res 2007 0.85
27 Interferon-gamma regulates oxidative stress during experimental autoimmune encephalomyelitis. Exp Neurol 2002 0.84
28 The mRNA expression profile of metabolic genes relative to MHC isoform pattern in human skeletal muscles. J Appl Physiol (1985) 2006 0.84
29 Effect of astrocyte-targeted production of IL-6 on traumatic brain injury and its impact on the cortical transcriptome. Dev Neurobiol 2008 0.84
30 Chemical blocking of zinc ions in CNS increases neuronal damage following traumatic brain injury (TBI) in mice. PLoS One 2010 0.84
31 Role of metallothionein-III following central nervous system damage. Neurobiol Dis 2003 0.83
32 The role of metallothionein II in neuronal differentiation and survival. Brain Res 2003 0.82
33 Metallic gold reduces TNFalpha expression, oxidative DNA damage and pro-apoptotic signals after experimental brain injury. Brain Res 2009 0.82
34 Metallothionein-1+2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6. Neurobiol Dis 2002 0.81
35 Intraneuronal signaling pathways of metallothionein. J Neurosci Res 2009 0.81
36 Analysis of the cerebral transcriptome in mice subjected to traumatic brain injury: importance of IL-6. Neuroimmunomodulation 2007 0.81
37 Plasmodium berghei ANKA: erythropoietin activates neural stem cells in an experimental cerebral malaria model. Exp Parasitol 2010 0.80
38 Altered expression of metallothionein-I and -II and their receptor megalin in inherited photoreceptor degeneration. Invest Ophthalmol Vis Sci 2010 0.79
39 Metallic gold slows disease progression, reduces cell death and induces astrogliosis while simultaneously increasing stem cell responses in an EAE rat model of multiple sclerosis. Histochem Cell Biol 2012 0.79
40 Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury. Histochem Cell Biol 2008 0.79
41 The synthetic NCAM-derived peptide, FGL, modulates the transcriptional response to traumatic brain injury. Neurosci Lett 2008 0.78
42 Metallic gold treatment reduces proliferation of inflammatory cells, increases expression of VEGF and FGF, and stimulates cell proliferation in the subventricular zone following experimental traumatic brain injury. Histol Histopathol 2009 0.78
43 Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation. Exp Biol Med (Maywood) 2006 0.77
44 Metallic silver fragments cause massive tissue loss in the mouse brain. Basic Clin Pharmacol Toxicol 2011 0.76
45 Bio-released gold ions modulate expression of neuroprotective and hematopoietic factors after brain injury. Brain Res 2009 0.76
46 Metallothionein expression and oxidative stress in the brain. Methods Enzymol 2002 0.75
47 The renal metallothionein expression profile is altered in human lupus nephritis. Arthritis Res Ther 2008 0.75
48 [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock]. Ugeskr Laeger 2008 0.75
49 Metallothionein-I + II and receptor megalin are altered in relation to oxidative stress in cerebral lymphomas. Leuk Lymphoma 2010 0.75